Authors:
Nieuwkerk, P
Gisolf, E
Sprangers, M
Danner, S
Citation: P. Nieuwkerk et al., Adherence over 48 weeks in an antiretroviral clinical trial: variable within patients, affected by toxicities and independently predictive of virological response, ANTIVIR TH, 6(2), 2001, pp. 97-103
Citation: S. Danner et Jg. Belasco, T7 phage display: A novel genetic selection system for cloning RNA-bindingproteins from cDNA libraries, P NAS US, 98(23), 2001, pp. 12954-12959
Authors:
Sommer, B
Barbieri, S
Hofele, K
Wiederhold, KH
Probst, A
Mistl, C
Danner, S
Kauffmann, S
Spooren, W
Tolnay, M
Bilbe, G
Van der Putten, H
Citation: B. Sommer et al., Lewy-like pathology in mice transgenic for mutant (A53T) and wild-type human alpha-synuclein, ALZHEIMER'S DISEASE, 2001, pp. 661-670
Authors:
Sommer, B
Barbieri, S
Hofele, K
Wiederhold, KH
Probst, A
Mistl, C
Danner, S
Kauffmann, S
Spooren, W
Tolnay, M
Bilbe, G
van der Putten, H
Kafmann, S
Caromi, P
Ruegg, MA
Citation: B. Sommer et al., Mouse models of alpha-synucleinopathy and Lewy pathology, EXP GERONT, 35(9-10), 2000, pp. 1389-1403
Authors:
van der Putten, H
Wiederhold, KH
Probst, A
Barbieri, S
Mistl, C
Danner, S
Kauffmann, S
Hofele, K
Spooren, WPJM
Ruegg, MA
Lin, S
Caroni, P
Sommer, B
Tolnay, M
Bilbe, G
Citation: H. Van Der Putten et al., Neuropathology in mice expressing human alpha-synuclein, J NEUROSC, 20(16), 2000, pp. 6021-6029
Authors:
Abrams, D
Allan, D
Antunes, F
Breckenridge, A
Bruun, J
Cameron, W
Carbon, C
Chalmers, I
Chang, H
Chodakewitz, J
Clendenin, N
Clumeck, N
Collier, A
Collins, G
Cooper, E
Cooper, D
Danner, S
D'Aquila, R
DeGruttola, V
DeMasi, R
Dee, L
Deyton, L
Dixon, D
Farthing, C
Feinberg, J
Fischl, M
Flepp, M
Gartland, M
Gatell, J
Gazzard, B
Goebel, F
Gotzsche, P
Gringeri, A
Hall, D
Hamilton, J
Hammer, S
Hartigan, P
Heath-Chiozzi, M
Henry, K
Hill, A
Hirschel, B
Ioannidis, J
Kahn, J
Katlama, C
Katzenstein, D
Killen, J
King, E
de Loes, SK
Kravcik, S
Lange, J
Leavitt, R
Leonard, J
Maeland, A
Mannucci, P
Mathiesen, L
McDade, H
Meibohn, A
Melander, H
Merigan, T
Mulder, J
Myers, M
Neaton, J
Nessling, M
Perrin, L
Pettinelli, C
Phair, J
Phillips, A
Pinching, A
Poppa, A
Power, L
Reiss, P
Richman, D
Rooney, J
Rousseau, F
Rutherford, G
Salgo, M
Sandstrom, E
Saravolatz, L
Savidge, G
Schnittman, S
Schooley, R
Seligmann, M
Simberkoff, M
Skowron, G
Slade, P
Smith, D
Smith, RP
Soriano, V
Stanley, K
Stingl, G
Stoffels, P
Struthers, L
Tierney, C
Thompson, M
Van der Broeck, R
Van Leeuven, R
Van Weverling, G
Veenstra, J
Vella, S
Volberding, P
Weber, J
Winslow, D
Yeni, P
Yeo, J
Dormont, J
Sande, M
Weller, I
Babiker, A
Collins, R
Darbyshire, J
Duncan, W
Foulkes, M
Hughes, M
Peto, R
Peto, T
Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025
Authors:
Plate, KH
Beck, H
Danner, S
Allegrini, PR
Wiessner, C
Citation: Kh. Plate et al., Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct, J NE EXP NE, 58(6), 1999, pp. 654-666
Authors:
Koot, M
van Leeuwen, R
de Goede, REY
Keet, IPM
Danner, S
Schattenkerk, JKME
Reiss, P
Tersmette, M
Lange, JMA
Schuitemaker, H
Citation: M. Koot et al., Conversion rate towards a syncytium-inducing (SI) phenotype during different stages of human immunodeficiency virus type 1 infection and prognostic value of SI phenotype for survival after AIDS diagnosis, J INFEC DIS, 179(1), 1999, pp. 254-258
Authors:
Bastian, LS
Kwiatkowski, BA
Breininger, J
Danner, S
Roth, G
Citation: Ls. Bastian et al., Regulation of the megakaryocytic glycoprotein IX promoter by the oncogenicEts transcription factor Fli-1, BLOOD, 93(8), 1999, pp. 2637-2644